BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37904139)

  • 1. Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.
    Liu Q; Zhang W; Pei Y; Tao H; Ma J; Li R; Zhang F; Wang L; Shen L; Liu Y; Jia X; Hu Y
    BMC Med; 2023 Oct; 21(1):409. PubMed ID: 37904139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
    Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
    Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
    PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity.
    Qiu J; Zhao L; Cheng Y; Chen Q; Xu Y; Lu Y; Gao J; Lei W; Yan C; Ling Z; Wu S
    Front Immunol; 2023; 14():1317809. PubMed ID: 38162661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for identification of the opportunistic gut mycobiome from colorectal adenocarcinoma biopsy tissues.
    Yunus A; Mokhtar NM; Raja Ali RA; Ahmad Kendong SM; Ahmad HF
    MethodsX; 2024 Jun; 12():102623. PubMed ID: 38435637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
    Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J
    EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients.
    Hu X; Wang H; Yu B; Yu J; Lu H; Sun J; Sun Y; Zou Y; Luo H; Zeng Z; Liu S; Jiang Y; Wu Z; Ren Z
    Adv Sci (Weinh); 2023 Jul; 10(19):e2205058. PubMed ID: 37119437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
    Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
    Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
    Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
    J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of four serum miRNAs for screening of lung adenocarcinoma.
    Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y
    Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.
    Chen C; Zhang Y; Yao X; Li S; Wang G; Huang Y; Yang Y; Zhang A; Liu C; Zhu D; Li H; Yan Q; Ma W
    Microbiol Spectr; 2023 Feb; 11(1):e0171122. PubMed ID: 36515546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
    Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mycobiome in murine intestine is more perturbed by food arsenic exposure than in excreted feces.
    Guo L; Dou X; Zou R; Guo X; Liu X; Tang H
    Sci Total Environ; 2021 Jan; 753():141871. PubMed ID: 32891997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
    Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
    Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma.
    Luo R; Zhong P; Li X; Cai J; Tao Y; Xiong B; Zheng H; Zhang Z; Tang L; Yao J; Li Y; Shi Y; Han X
    Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):726-738. PubMed ID: 36857775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.